Influence of preoperative leg pain and radiculopathy on outcomes in mono-segmental lumbar total disc replacement: results from a nationwide registry by Zweig, Thomas et al.
ORIGINAL ARTICLE
Influence of preoperative leg pain and radiculopathy on outcomes
in mono-segmental lumbar total disc replacement: results
from a nationwide registry
Thomas Zweig • Emin Aghayev • Markus Melloh •
Daniel Dietrich • Christoph Ro¨der •
SWISSspine Registry Group
Received: 17 May 2011 / Accepted: 22 May 2011 / Published online: 10 June 2011
 Springer-Verlag 2011
Abstract
Purpose Currently, many pre-conditions are regarded as
relative or absolute contraindications for lumbar total disc
replacement (TDR). Radiculopathy is one among them. In
Switzerland it is left to the surgeon’s discretion when to
operate if he adheres to a list of pre-defined indications.
Contraindications, however, are less clearly specified. We
hypothesized that, the extent of pre-operative radiculopathy
results in different benefits for patients treated with mono-
segmental lumbar TDR. We used patient perceived leg
pain and its correlation with physician recorded radicu-
lopathy for creating the patient groups to be compared.
Methods The present study is based on the dataset of
SWISSspine, a government mandated health technology
assessment registry. Between March 2005 and April 2009,
577 patients underwent either mono- or bi-segmental
lumbar TDR, which was documented in a prospective
observational multicenter mode. A total of 416 cases with a
mono-segmental procedure were included in the study. The
data collection consisted of pre-operative and follow-up
data (physician based) and clinical outcomes (NASS form,
EQ-5D). A receiver operating characteristic (ROC) analy-
sis was conducted with patients’ self-indicated leg pain and
the surgeon-based diagnosis ‘‘radiculopathy’’, as marked
on the case report forms. As a result, patients were divided
into two groups according to the severity of leg pain. The
two groups were compared with regard to the pre-operative
patient characteristics and pre- and post-operative pain on
Visual Analogue Scale (VAS) and quality of life using
general linear modeling.
Results The optimal ROC model revealed a leg pain
threshold of 40 B VAS [ 40 for the absence or the presence
of ‘‘radiculopathy’’. Demographics in the resulting two groups
were well comparable. Applying this threshold, the mean pre-
operative leg pain level was 16.5 points in group 1 and 68.1
points in group 2 (p \ 0.001). Back pain levels differed less
with 63.6 points in group 1 and 72.6 in group 2 (p \ 0.001).
Pre-operative quality of life showed considerable differences
with an 0.44 EQ-5D score in group 1 and 0.29 in group 2
(p \ 0.001, possible score range -0.6 to 1). At a mean follow-
up time of 8 months, group 1 showed a mean leg pain
improvement of 3.6 points and group 2 of 41.1 points
(p \ 0.001). Back pain relief was 35.6 and 39.1 points,
respectively (p = 0.27). EQ-5D score improvement was 0.27
in group 1 and 0.41 in group 2 (p = 0.11).
Conclusions Patients labeled as having radiculopathy
(group 2) do mostly have pre-operative leg pain lev-
els C 40. Applying this threshold, the patients with pre-
operative leg pain do also have more severe back pain and
a considerably lower quality of life. Their net benefit from
the lumbar TDR is higher and they do have similar post-
operative back and leg pain levels as well as the quality of
life as patients without pre-operative leg pain. Although
randomized controlled trials are required to confirm these
findings, they put leg pain and radiculopathy into per-
spective as absolute contraindications for TDR.
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Introduction
Because of the reported long convalescence periods after
spinal fusion and a presumed risk of adjacent segment
degeneration, patients increasingly consider the opportu-
nity of total disc replacement (TDR). Disc herniation (DH)
is the widely accepted cause of leg pain. Looking at the
published results for the classic posterior procedures such
as conventional discectomy, microdiscectomy and percu-
taneous measures for treating DH, we observed heteroge-
neous results. Reported re-operation rates range between 0
and 18% [1, 2] and back or leg pain persist in 6–43% [1] of
cases, emphasizing the necessity for clear-cut indications.
These results show that an appreciable population is
unsatisfied or re-operated. The aforementioned facts out-
line the demands for a single staged solution with sus-
tainable long-term results for which the success rates of
only 75 –80% for the classic posterior procedure (lumbar
discectomy) should not be the goal [3].
In contrast to the European administrations, the Food
and Drug Administration (FDA) approved the first TDR for
the lumbar spine very late. It was the SB Charite´/DePuy
Spine in October 2004 [4, 5] followed by the approval of
the Synthes ProDisc-L in August 2006 [6]. Considering the
publications by TDR pioneers [7, 8] and studies leading to
FDA approval, indications and contraindications for TDR
were defined [4, 9, 10].
The generally accepted indications are:
Single-level degenerative disc disease (DDD) between
L4-S1 confirmed by magnetic resonance imaging (MRI),
computed tomography (CT) and/or CT myelography;
discogenic low back pain (LBP) at the segment to be
operated concordant with the pain during the provocative
discography;
back and/or leg pain without neural compression;
age between 18 and 60 years;
unsuccessful conservative therapy of at least 6 months
duration.
Contraindications are determined as follows:
DH with neural compression, spondylolisthesis and
spondylolysis,
central or lateral recess stenosis,
facet joint degeneration,
scoliosis and
osteopenia.
There are about 50 other contraindications according to
the work of Wong et al. [11].
However, the current literature presents only a few
studies dealing with the prevalence of indications and
contraindications for TDR.
This suggests the need for randomized controlled trials
(RCTs) comparing the fusion techniques or posterior
techniques with motion preserving procedures, but their
implementation remains difficult because of its various
limitations [6, 12–14].
In the history of TDR development, many biomechani-
cal concepts were brought up and drawbacks were seen
[15, 16]. One widely noticed article raising concerns [17]
led the Swiss Federal Office of Public Health to tempo-
rarily link the reimbursement of TDR to mandatory par-
ticipation in a HTA registry. Following the governmental
request for close monitoring of all TDR procedures, a
nationwide registry was implemented according to the prin-
ciple of ‘‘coverage with evidence development’’ [18, 19].
As a nationwide data collection project, the SWISSspine
registry opened opportunities for investigations with a
potentially high external validity. Amongst the most
interesting topics were the indications and contraindica-
tions for lumbar TDR. In the framework of the registry and
in the day-to-day routine clinical practice it was left to the
surgeon’s discretion to operate on patients with leg pain or
radiculopathy. Taking into account the potentially wide
range of cases and symptoms we hypothesized that pre-
operative presence or absence of leg pain or radiculopathy
results in different benefits for patients treated with mono-
segmental lumbar TDR. Therefore, the aim of current study
was to compare the outcome of TDA in patients with different
levels of radiculopathy, using patient perceived leg pain and
its correlation with physician recorded radiculopathy for
creating the patient groups to be compared.
Materials and methods
Between March 2005 and April 2009, 577 patients with
lumbar TDR were documented. The following implants
were used:
ActiveL, Braun/Aesculap, Tuttlingen, Germany;
Dynardi, Zimmer, Warsaw, IN, USA;
Maverick, Medtronic Sofamor Danek, Memphis, TN,
USA;
ProDisc II, Spine Solutions/Synthes, Paoli, PA, USA;
SB Charite´, DePuy Spine, Raynham, MA, USA.
A total of 416 patients with a mono-segmental inter-
vention and complete datasets were included in this study.
43% were male and 57% female with a mean age of
43.3 years (range 19.5–64.7 years) and 41.2 years (range
18.5–64.6 years), respectively. In total 967 lumbar TDR
follow-up records with a follow-up time from 24 days to
4.2 years were completed and stored in the MEMdoc
database at the University of Bern. Furthermore, 1,397
EuroQol-5D (EQ-5D) forms, 416 perioperative physician
based records, 984 physician documented follow-ups and
1,373 NASS outcome forms were gathered. Mean follow-
up time using the latest available patient based assessment
during the first year was 8 months (range 33–399 days).
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In this study, we compared two patient groups with
regard to the presence or absence of leg pain or radicu-
lopathy. Radiculopathy was based on pre-operative exam-
ination as indicated by the surgeon on the case report form.
Leg pain was independently indicated by the patients using
the VAS on the NASS form.
Patient based assessment
Pain was assessed using two separate VAS for back and leg
pain, both located on the NASS form. General quality of
life was assessed using EQ-5D. In this cost-utility based
instrument values range from -0.6 (quality of life worse
than death) via 0 (quality of life equals death) to 1 (best
possible quality of life).
Statistical analysis
The receiver operating characteristic (ROC) curve based
on the univariate logistic regression was used to discrimi-
nate the best cut-off leg pain score for distinguishing
between the physician diagnosed ‘‘radiculopathy’’ and ‘‘no
radiculopathy’’.
Descriptive statistics for patient characteristics were
calculated for each group. Comparisons between the
groups regarding patient characteristics were performed
using chi-square and Wilcoxon rank-sum tests where
applicable. Pre- and post-operative values, as well as pre-
to post-operative differences of the two groups were
compared using general linear modeling. Thereby Bon-
ferroni–Holm adjustments were set to account for multiple
testing between the groups. Correction factors of gender,
age, medication, and level of the intervention were applied
for all the outcome variables.
All statistical analyses were conducted using SAS 9.2
(SAS Institute Inc, Cary, NC) and statistical significance
was accepted at the p \ 0.05 level.
Results
ROC analysis
The analysis resulted in 40 VAS points as the best cut-off
value for patients with or without physician diagnosed
radiculopathy. Applying this cut-off sensitivity for the
presence or absence of leg pain in diagnosing radiculopa-
thy was 73%, the specificity 45%.
Two groups
Based on the cut-off value two study groups were defined.
Group 1 consisted of 111 (26.2%) patients with pre-
operative leg pain levels below 40. The remaining 313
patients with leg pain above 40 were allocated in group 2.
There were no significant differences between the two
groups with respect to mean age, gender distribution, types
of work, and work ability or pre-operative medication and
distribution of operated levels (Table 1).
VAS back pain
The average pre-operative back pain was 63.6 points in
group 1 and 72.6 points in group 2 (p \ 0.001). Post-
operative back pain was 28 points in group 1 and 33.5
points in group 2 (p = 0.10). The average back pain alle-
viation in group 1 was 35.6 points and in group 2 was 39.1
points (p = 0.27). 72% of patients reached the minimum
clinically relevant pain improvement (MCRPI) of 20 points
for back pain in group 1 and 75% in group 2 (p = 0.55)
(Fig. 1; Table 2).
VAS leg pain
The average pre-operative leg pain was 16.5 points in
group 1 and 68.1 points in group 2 (p \ 0.001). Post-
operative leg pain was 12.9 points in group 1 and 27 points
in group 2 (p \ 0.001). The average leg pain alleviation in
group 1 was 3.6 points and in group 2 it was 41.1 points
(p \ 0.001) (Fig. 2; Table 2).
Quality of Life (EQ-5D)
The average pre-operative EQ-5D score was 0.44 points in
group 1 and 0.29 points in group 2 (p \ 0.001). The post-
operative score was 0.78 points in group 1 and 0.71 points
in group 2 (p = 0.049). The average EQ-5D score
improvement in group 1 was 0.27 points and in group 2 it
was 0.41 points (p = 0.11). 53% of patients in group 1
reached at least 0.25 points of EQ-5D score improvement
and 59% in group 2 (p = 0.26) (Fig. 3).
Discussion
Based on several studies the FDA approved lumbar TDR
with some exclusion criteria and many authors consider
radiculopathy and leg pain as non-favourable precondi-
tions [20]. Others, however, like Zigler et al. [13]
described TDR as an option in these patients. In general,
indications and contraindications have never been con-
sequently adapted to newer results and a worldwide
uncertainty still remains.
With data based on widely used and validated outcome
instruments (EQ-5D, NASS–VAS) and on information
recorded by the surgeons pre- and post-operatively we can
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draw an image of the impact of TDR-surgery on patient’s
quality of life.
This study hypothesized that there are differences in out-
come between the two patient groups defined by the presence
or absence of radiculopathy and the extent of leg pain.
We found no differences in back pain relief and, simi-
larly, post-operative leg pain levels were not significantly
different either. Relative leg pain relief, however, differed
between the two groups. The fact that patients with
different pre-operative leg pain levels had similarly low
Table 1 Patient characteristics
at baseline
NS not significant
Group 1
n = 110 (leg pain
\40 VAS)
Group 2
n = 313 (leg pain C40
VAS)
Group comparison
(p value)
Mean age (years) 41.3 42.5 NS
Age range (years) 21–64 19–65 NS
Females (%) 61.8 58.2 NS
Occupat. sedentary work
(%)
31.6 27 NS
Occupat. physical work
(%)
57.9 51.4
Occupat. housewife (%) 9.5 15.2
Occupat. retired (%) – 2
Occupat. unemployed (%) 1 4.4
Ability to work 90–100%
(%)
65 52.4 NS
Ability to work 50–90%
(%)
11.2 16.6
Ability to work 0-50% (%) 7.5 6.1
Unable to work (%) 16.3 24.9
No pre-operative
medication (%)
3.6 2.2 NS
Pre-operative NSAIDs (%) 88.2 81.5 NS
Pre-operative opioids (%) 35.5 37.4 NS
L2/3 (%) 1 0.7 NS
L3/4 (%) 7.8 4.3
L4/5 (%) 42.7 44.6
L5/S1 (%) 48.5 50.4
Fig. 1 Pre- and post-operative
back pain levels and pre- to
post-operative back pain
alleviation of the two groups of
patients
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Table 2 Outcomes
Group 1 (n = 111) Group 2 (n = 313)
Outcome Pre-operative Post-operative Change Pre-operative Post-operative Change
VAS back 63.6 28 35.6 72.6 33.5 39.1
VAS leg 16.5 12.9 3.6 68.1 27 41.1
EQ-5D 0.440 0.776 0.335 0.290 0.706 0.419
Fig. 2 Pre- and post-operative
leg pain levels and pre- to post-
operative leg pain alleviation of
the two groups of patients
Fig. 3 Pre- and post-operative
quality of life (EQ-5D) and pre-
to post-operative quality of life
improvement of the two groups
of patients
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post-operative pain levels shows that those with higher pre-
operative leg pain had a higher benefit from the procedure.
These findings challenge some of the previous limitations
for TDR.
Leg pain and its relief have an obviously large impact on
the patient’s quality of life. Despite significantly different
pre- and also post-operative EQ-5D scores, the absolute
score differences between the groups were halfened, from
0.15 EQ-5D score points before to 0.07 points after
surgery.
Recent publications focus on TDR as a sound twenty
first century approach. Hopes and appraisals but even more
polemics can be found [21, 22]. Ross et al. [23] evaluated
226 SB Charite´ III TDRs in 160 patients concluding that
‘‘These poor results indicate that the further use of this
implant is not justified’’. In contrast, Mayer et al. and Siepe
et al. [24] described the good results for the ProDisc II by
even applying less invasive approaches. Since the alarming
results of the Acroflex-Disc study [25] and the ongoing US
court cases concerning the SB Charite´ [26], the Swiss
health care authorities were reluctant to accept TDR as a
safe and efficacious therapy. Therefore, a nationwide reg-
istry was mandated to closely monitor TDR in the less
controlled clinical settings [19, 27]. Mirza [28] commented
on important issues like polyethylene wear, loosening, as
well as infection, and concluded that the hopes for a cure of
back pain and a marketing bonanza must be held in check
by the principles of fairness and responsibility and by long-
term results.
Published reports like that of Chin et al. [10] suggested
that 95% of patients undergoing lumbar spinal surgery had
at least one contraindication for TDR. These conclusions
do, however, depend upon the definitions of indications and
contraindications of lumbar TDR.
According to the current literature patients having
pathomorphological changes, such as DH or recess stenosis
with consequent leg pain should not undergo lumbar TDR.
Hence, patients presented in this study as group 2 are not
accepted as ideal candidates to date [13].
Indications and contraindications will continue to evolve
with the improved understanding of this procedure.
Changing them might allow conceivably more patients or
better selected patients to be considered for lumbar TDR
[29]. Is this desirable? For sure, the optimized indication
has highest priority for long-term outcomes of the proce-
dure. The immediate perceived success obtained with the
BAK cage for symptomatic DDD created an environment
in which the indications were loosely modified and sub-
optimal surgical candidates were stabilized with accord-
ingly poorer results.
SWISSspine is a prospective observational study of a
large cohort of TDR recipients. Using the latest available
follow-up record of each patient in the first year we found
no outcome differences between the patients with and
without leg pain or radiculopathy. Although German and
Foley [30] compared the literature concerning both TDR
and stand-alone ALIF trying to identify the parallels, they
concluded that the given obstacles are difficult to
overcome.
To date ALIF seems to be the only comparator for TDR
but it is a weak one, especially regarding to biomechanics.
The hurdles to overcome when creating and running RCTs
comparing TDR to ALIF are high, but it was done by
Geisler, Guyer, Blumenthal or McAfee [12, 13, 31]. Their
results showed a similar patient satisfaction and a slight
superiority for TDR in several socio-economic areas such
as work status and duration of hospitalization.
Our study has several limitations. The follow-up time is
rather short when compared to other studies [7, 24] and it is
based on registry data. Therefore, the limitations have to be
considered in the analysis and interpretation of such data.
Invalid conclusions can result when insufficient attention is
paid to issues such as missing data, sources of bias and data
quality. The interpretation of the symptom ‘‘radiculopathy’’
is widespread and examiners’ subjectivity has influence on
that variable. SWISSspine the surgeon determines if a
radiculopathy is present or not and in some cases a false
radiculopathy with pain above the knees may have been
labelled as a true one, which is defined as pain that follows
a dermatomal pattern radiating below the knee and into the
foot and/or toes [32, 33]. In the current study, however,
both the groups are comprised of more than 90% L4/L5
and L5/S1 pathologies. Clinical experience tells us that
radicular pain caused by these nerve roots is less prone to
misinterpretation.
In addition, a previous analysis revealed a very stable
course of post-operative back pain and even an ongoing
further improvement of leg pain until 400 days after sur-
gery [19].
In the literature there is little information on this issue
but we have to be aware that in high percentages of patients
there is a clear and substantial reason for leg pain.
On the other hand, data collection in SWISSspine is
multicentric and due to its setting the registry reaches a
very high level of representativeness, i.e. external validity
since the likelihood of a systematic selection bias of
patients is low.
Conclusion
Our study revealed a relatively higher benefit from lumbar
TDR procedures in patients that actually carry widely
accepted relative contraindications like leg pain. Despite
leg pain or pre-operative radiculopathy short-term out-
comes were similar to patients without these pathologies.
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Consequently, the current agreements on indications and
contraindications for lumbar TDA are challenged and our
findings should be confirmed in trials with higher evidence
levels.
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